✦ LIBER ✦

Genetic polymorphism of urokinase-type plasminogen activator is interacting with plasminogen activator inhibitor-1 to raise risk of cervical neoplasia

✍ Scribed by Yi-Torng Tee; Po-Hui Wang; Hsiu-Ting Tsai; Long-Yau Lin; Hung-Ting Lin; Shun-Fa Yang; Yi-Hsien Hsieh; Tsung-Ho Ying

Book ID: 112135962
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 78 KB
Volume: 106
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.23072

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Urokinase-Type Plasminogen Activator/Typ

Urokinase-Type Plasminogen Activator/Type-2 Plasminogen-Activator Inhibitor Complexes are not Internalized Upon Binding to the Urokinase-Type-Plasminogen-Activator Receptor in THP-1 Cells : Interaction of Urokinase-Type Plasminogen Activator/Type-2 Plasminogen-Activator Inhibitor Complexes with the Cell Surface

✍ Pia Ragno; Nunzia Montuori; Guido Rossi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 693 KB

Genetic polymorphism of the plasminogen

Genetic polymorphism of the plasminogen activator inhibitor-1 is associated with an increased risk of endometrial cancer

✍ Chung-Kuang Su; Kun-Tu Yeh; Chao-Bin Yeh; Po-Hui Wang; Esther Shih-Chu Ho; Ming- 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Urokinase binding and catabolism by Hep

Urokinase binding and catabolism by Hep G2 cells is plasminogen activator inhibitor-1 dependent, analogous to interactions of tissue-type plasminogen activator with these cells

✍ Philip G. Grimsley; John F. Normyle; Ruth A. Brandt; Georgina Joulianos; Colin N 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 637 KB

239 The 4G/5G genetic polymorphism of th

239 The 4G/5G genetic polymorphism of the plasminogen activator inhibitor-1 (PAI-1) promoter is not associated with the plasma PAI-1 levels in newborns

📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 101 KB

An Insertion/Deletion polymorphism in th

An Insertion/Deletion polymorphism in the promoter region of the plasminogen activator inhibitor-1 gene is associated with plasma levels but not with stroke risk in the elderly

✍ Lise Leth Jeppesen; Kirk Wilhelmsen; Lars Bo Nielsen; Henrik Stig Jørgensen; Hir 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 666 KB

Dedifferentiation of serous ovarian canc

Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1)

✍ Christer Borgfeldt; Stefan R. Hansson; Barbro Gustavsson; Anna Måsbäck; Bertil C 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 337 KB 👁 1 views

The plasminogen activating system is involved in tumor growth and metastasis by degradation of extracellular matrix, and modulation of cell adhesion and migration. Benign and well-differentiated malignant ovarian tumors present as cystic lesions with preserved glandular morphology, whereas poorly di